Ischemic stroke is a leading cause of death worldwide. A key secondary cell death
mechanism mediating neurological damage following the initial episode of ischemic stroke …

In recent years, stem cell‐based approaches have attracted more attention from scientists
and clinicians due to their possible therapeutical effect on stroke. Animal studies have …

Placental structures, capable to persist in a genetically foreign organism, are a natural
model of allogeneic engraftment carrying a number of distinctive properties. In this review …

In the 1800s, a baby born with a caul, a remnant of the amniotic sack or fetal membranes,
was thought to be lucky, special, or protected. Over time, fetal membranes lost their …

Stroke, the most prevalent cerebrovascular disease, causes serious loss of neurological
function and is the leading cause of morbidity and mortality worldwide. Despite advances in …

MicroRNAs (miRNAs) have emerged as potential cancer therapeutics; however, their clinical
use is hindered by lack of effective delivery mechanisms to tumor sites. Mesenchymal stem …

Cell therapy is emerging as a viable therapy to restore neurological function after stroke.
Many types of stem/progenitor cells from different sources have been explored for their …

Cell therapies are increasingly recognized as a promising option to augment the limited
therapeutic arsenal available to fight ischemic stroke. During the last two decades …

Aim The effectiveness of nanofibers containing human placenta-derived mesenchymal stem
cells (hPDMSCs) plus platelet-rich plasma (PRP) for healing of diabetic foot ulcers (DFUs) …

Based on their ability to regulate immune responses, MSCs are considered to be potential
candidates for managing immune-mediated diseases in the context of immune therapy. AT …